Loading chat...
NY S09279
Bill
Status
Introduced
2/24/2026
Primary Sponsor
Michael Gianaris
Click for details
AI Summary
- Requires gene synthesis providers and manufacturers of gene synthesis equipment to operate according to rules and regulations issued by the New York Department of Health
- Defines "gene synthesis provider" as any entity that synthesizes and distributes synthetic nucleic acids to customers or distributors
- Directs the Department of Health to utilize generally accepted industry standards when drafting regulations
- Requires the department to consider recommendations and protocols from the International Gene Synthesis Consortium and similar recognized organizations
- Officially titled the "Bioterrorism Prevention Act" and takes effect immediately upon passage
Legislative Description
Requires gene synthesis providers and manufacturers of gene synthesis equipment to operate in accordance with rules and regulations issued by the department of health, including identifying potentially dangerous sequences and maintaining certain records.
Last Action
PRINT NUMBER 9279A
3/13/2026
Committee Referrals
Health2/24/2026
Full Bill Text
No bill text available